Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model

Neuropharmacology

Volumn 42, Issue 8, 2002, Pages 1056-1064

  Sawada, Hideyuki ^a   Ibi, Masakazu ^a   Kihara, Takeshi ^a   Honda, Kazuhiro ^a   Nakamizo, Tomoki ^a   Kanki, Rie ^a   Nakanishi, Miki ^a   Sakka, Noriko ^a   Akaike, Akinori ^a   Shimohama, Shun ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

17 Estradiol; C Jun AP 1 pathway; Parkinson s disease; Transcription factor

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 17ALPHA ESTRADIOL; CASPASE INHIBITOR; CURCUMIN; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; RECEPTOR BLOCKING AGENT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; YP 537;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIMERIZATION; DISEASE MODEL; EMBRYO; ENZYME REGULATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; TRANSCRIPTION REGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; CELL DEATH; CELLS, CULTURED; DOPAMINE; EMBRYO; ESTRADIOL; ESTROGEN RECEPTOR BETA; FEMALE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MESENCEPHALON; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PARKINSONIAN DISORDERS; PREGNANCY; RATS; RECEPTORS, ESTROGEN;

EID: 0036070328     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00049-7     Document Type: Article

References (41)

1. An antiestrogen: A phophotyrosyl peptide that blocks dimerization of the human estrogen receptor
2. L-dopa treatment of Parkinson’s disease: A ten-year follow up study
3. Revised guide for the care and use of laboratory animals available
4. Stereospecific prevention by 17β-estradiol of MPTP-induced dopamine depletion in mice
5. Neuroprotective properties of 17β-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice
6. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
7. Uric acid is reduced in the substantia nigra in Parkinson’s disease: Effect on dopamine oxidation
8. Mechanisms of action of steroid hormones
9. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors
10. The oxidant stress hypothesis in Parkinson’s disease: Evidence supporting it
11. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence
12. Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice
13. 17 α-estradiol exerts neuroprotective effects on SK-N-SH cells
14. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells
15. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells
16. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
17. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
18. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
19. Cloning of a novel receptor expressed in rat prostate and ovary
20. The ubiquitin pathway in Parkinson’s disease
21. A prevalence survey of Parkinson’s disease and other movement disorders in the People’s Republic of China
22. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
23. + and mitochondrial function
24. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
25. 17β-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
26. Mutation in the α-synuclein gene identified in families with Parkinson’s disease
27. +
28. MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo
29. The effect of estrogen replacement on early Parkinson’s disease
30. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
31. Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons
32. Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalicneurons
33. Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture
34. Mechanism of resistance to NO-induced neurotoxicity in cultured rat dopaminergic neurons
35. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells
36. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system
37. Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia
38. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
39. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations
40. 2-terminal kinase pathway in H9c2 cardiac muscle cells
41. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis